| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $9.7M | +9.7% |
| SG&A Expense | $10.5M | -18.6% |
| Operating Income | -$20.2M | +7.1% |
| Interest Expense | $100K | -85.7% |
| Pre-tax Income | -$20.0M | +9.7% |
| Income Tax | $15K | +7.1% |
| Net Income | -$19.9M | +10.1% |
| EPS (Basic) | -$5.95 | -100.3% |
| EPS (Diluted) | -$5.95 | -100.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $6.3M | -38.8% |
| Total Assets | $8.9M | -37.5% |
| Current Liabilities | $3.9M | -58.6% |
| Long-term Debt | $600K | +0.0% |
| Total Liabilities | $5.1M | -58.3% |
| Stockholders' Equity | $3.8M | +145.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.3M | -8.1% |
| Investing Cash Flow | -$170K | -962.5% |
| Financing Cash Flow | $17.5M | -36.2% |